Fundz

Caldera Therapeutics reported raising $37.5 Million in an initial SEC Form D filing, from an offering of $37.5 Million

PRIVATEJan 21, 2026

Amount Raised

$37.5 Million

$37.5 Million sold, per SEC Form D (first sale Jan 8, 2026)

Round Type

Venture

CambridgeBiotechnologyTherapeutics

Quick answer

Caldera Therapeutics raised $37.5 Million in a funding round, dated January 8, 2026. Caldera Therapeutics is based in Cambridge, Massachusetts, United States.

How much did Caldera Therapeutics raise?
Caldera Therapeutics raised $37.5 Million in a funding round on January 8, 2026.
What does Caldera Therapeutics do?
Caldera Therapeutics is a clinical stage biotechnology company developing CLD-423, a first-in-class bispecific antibody targeting the clinically validated IL-23p19 and TL1A pathways for the treatment of inflammatory..
Where is Caldera Therapeutics based and how big is it?
Caldera Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 4 employees.
Who are the decision-makers at Caldera Therapeutics?
Fundz holds 2 contacts at Caldera Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Caldera Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Peptis raised $7.7M (Series A) on February 21, 2026.
  • Altesa raised $75M (Series B) on February 19, 2026.
  • Lario Therapeutics raised $2.4M (Grant) on February 19, 2026.
  • Sift Biosciences raised $3.7M (Pre-Seed) on February 18, 2026.
  • Faeth Therapeutics raised $200M (Post-IPO Equity) on February 18, 2026.
  • Korsana Biosciences raised $175M (Series A) on February 18, 2026.

Who to call at Caldera Therapeutics, and when

A new round usually means Caldera Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Caldera Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Caldera Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Caldera Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Caldera Therapeutics

Location

Cambridge, Massachusetts, United States

About

Caldera Therapeutics is a clinical stage biotechnology company developing CLD-423, a first-in-class bispecific antibody targeting the clinically validated IL-23p19 and TL1A pathways for the treatment of inflammatory bowel disease (IBD) and other immunologic and inflammatory diseases. The company aims to advance innovative biologics in IBD and has a senior leadership team with extensive experience in this field. Caldera has raised significant funding from renowned biotech investors to support its development programs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Caldera Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Caldera Therapeutics's next move

See what Strategic adds

Caldera Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.